OOptionStarter

Company Research

Leidos Holdings, Inc. (LDOS)

Scanner score: 48.00Price: $123.10ROE: 27.78%Margin of safety: 57.79%

First analyzed: 2026-09-29

Part 1

Company Overview

Leidos is a large, government-focused technology and mission-services contractor whose durable advantages are customer trust, contract vehicles, security clearances, domain expertise, and scale, but whose long-term economics remain exposed to federal budgets, recompetes, contract execution, and acquisition integration.

Business Model

Overview

  • Leidos provides technology, engineering, systems integration, health services, security products, and mission-support services to government and commercial customers.
  • The company earns revenue primarily through negotiated contracts as a prime contractor or subcontractor. Its offerings include software and digital services, cyber and intelligence support, defense systems, managed health services, transportation and security systems, engineering, and critical-infrastructure services.
  • Beginning in fiscal 2026, Leidos realigned its reporting structure into four segments: Intelligence & Digital, Health, Homeland, and Defense. Prior-year results were recast for comparison.

Segments

  • Segment

    Intelligence & Digital

    Description

    Supports intelligence, defense, cyber, digital modernization, mission software, analytics, and related technology programs.

    Fiscal 2025 Revenue

    $7.365 billion under the prior reporting structure, equal to approximately 44.2% of company revenue.

    Current 2026 Indicator

    Revenue was $3.012 billion in the first six months of fiscal 2026, or approximately 33.6% of company revenue for that period.

  • Segment

    Health

    Description

    Provides health-services administration, military and veteran health support, medical evaluations, clinical services, and related technology.

    Fiscal 2025 Revenue

    $5.015 billion under the prior reporting structure, equal to approximately 30.1% of company revenue.

    Current 2026 Indicator

    Revenue was $2.274 billion in the first six months of fiscal 2026, or approximately 25.4% of company revenue for that period.

  • Segment

    Homeland

    Description

    Provides transportation security, border and immigration systems, aviation and airport technology, screening systems, infrastructure engineering, and related homeland-security services. The 2026 segment includes the acquired Entrust power and utilities engineering business.

    Fiscal 2025 Revenue

    The comparable prior structure reported $2.252 billion for Commercial & International, equal to approximately 13.5% of fiscal 2025 company revenue. This is not directly comparable with the current Homeland segment because the reporting composition changed.

    Current 2026 Indicator

    Revenue was $1.834 billion in the first six months of fiscal 2026, or approximately 20.5% of company revenue for that period, including $152 million of Entrust revenue.

  • Segment

    Defense

    Description

    Provides defense platforms, systems engineering, research and development, space and missile-related capabilities, naval and aerospace support, and other defense products and services.

    Fiscal 2025 Revenue

    $2.030 billion under the prior reporting structure, equal to approximately 12.2% of company revenue.

    Current 2026 Indicator

    Revenue was $1.838 billion in the first six months of fiscal 2026, or approximately 20.5% of company revenue for that period.

Revenue Split

Fiscal 2025 Total Revenue

$16.662 billion for the fiscal year ended January 2, 2026.

Fiscal 2025 Segment Split

  • National Security & Digital: $7.365 billion, approximately 44.2%.
  • Health & Civil: $5.015 billion, approximately 30.1%.
  • Commercial & International: $2.252 billion, approximately 13.5%.
  • Defense Systems: $2.030 billion, approximately 12.2%.

Fiscal 2025 Geography

  • United States: $15.703 billion, approximately 91.8% of revenue.
  • International: $1.404 billion, approximately 8.2% of revenue.

Government Exposure

  • Approximately 87% of fiscal 2025 revenue came from contracts with the U.S. government, either directly or through subcontracting arrangements.
  • Contracts involving the Department of War and the U.S. Intelligence Community represented approximately 49% of fiscal 2025 revenue.
  • In the first six months of fiscal 2026, approximately 85% of revenue came from U.S. government contracts and approximately 8% came from international customers.

Main Customers

  • Major customers include the U.S. Department of War, U.S. Intelligence Community, Department of Homeland Security, Federal Aviation Administration, Department of Veterans Affairs, Defense Health Agency, Transportation Security Administration, Customs and Border Protection, military services, civilian agencies, state and local governments, foreign governments, NATO, and commercial customers.
  • International customers specifically identified by Leidos include the United Kingdom Ministry of Defence, Australian Department of Defence, and NATO.

Revenue Character

  • Revenue is contract-based and relatively visible because of funded backlog, multiyear contracts, and task orders, but it is not predominantly subscription revenue.
  • The business is best described as recurring and programmatic rather than contractual annuity-like. Customers frequently renew, recompete, or expand programs, but individual contracts can end, be delayed, lose recompetes, or experience funding changes.
  • Leidos has a mixture of cost-reimbursement, fixed-price-incentive, firm-fixed-price, time-and-materials, and fixed-price-level-of-effort contracts. Firm-fixed-price work can offer attractive margins but creates greater execution risk if costs exceed estimates.
  • The business is less economically cyclical than commercial technology or industrial businesses because national-security and public-sector demand is supported by government budgets, but it remains sensitive to appropriations, continuing resolutions, shutdowns, changing priorities, inflation, contract protests, and competitive rebids.

Backlog

  • As of July 3, 2026, total estimated backlog was $48.711 billion, including $10.223 billion of funded backlog and $38.488 billion of unfunded backlog.
  • Backlog includes negotiated contracts and certain sole-source IDIQ task orders considered probable, but it excludes potential task orders under multiple-award IDIQ contracts. Therefore, backlog is an indicator of revenue visibility rather than guaranteed future revenue.

History

Origin

  • The company traces its origins to 1969, when physicist J. Robert Beyster founded Science Applications International Corporation.
  • The modern Leidos entity was created through the 2013 separation of the original SAIC. On September 27, 2013, the technical-services and enterprise-information-technology business became the separately traded company named Science Applications International Corporation, while the remaining business was renamed Leidos Holdings.

Key Milestones

  • Date

    September 27, 2013

    Event

    SAIC separation and rebranding created Leidos as an independent public company focused on defense, intelligence, health, engineering, and related technology markets.

  • Date

    August 16, 2016

    Event

    Leidos completed its combination with Lockheed Martin's Information Systems & Global Solutions business through a Reverse Morris Trust transaction. The transaction substantially increased Leidos's scale in federal information technology, systems integration, and mission support.

  • Date

    August 15, 2019

    Event

    Leidos acquired IMX Medical Management Services, expanding its independent medical evaluation capabilities.

  • Date

    January 31, 2020

    Event

    Leidos acquired Dynetics for approximately $1.6 billion, adding applied research, advanced defense, space, hypersonics, and national-security capabilities.

  • Date

    May 4, 2020

    Event

    Leidos acquired the Security Detection & Automation businesses of L3Harris for approximately $1.0 billion, expanding aviation, transportation-security, screening, and automation capabilities.

  • Date

    2021

    Event

    Leidos acquired Gibbs & Cox, adding naval architecture, marine engineering, and ship-design capabilities.

  • Date

    May 3, 2023

    Event

    Thomas A. Bell became chief executive officer, succeeding Roger Krone. Robert Shapard became independent board chair.

  • Date

    May 23, 2025

    Event

    Leidos acquired Savanna Industries, known as Kudu Dynamics, to strengthen cyber and specialized digital capabilities.

  • Date

    March 27, 2026

    Event

    Leidos completed its acquisition of Entrust Solutions Group for approximately $2.4 billion, adding utility engineering, power, and infrastructure-design capabilities.

Leadership

  • Roger Krone served as chairman and chief executive officer from 2014 until 2023 and led the company through the Lockheed Martin IS&GS combination and the Dynetics and L3Harris acquisitions.
  • Thomas A. Bell has served as chief executive officer since May 3, 2023. His background includes senior leadership at Rolls-Royce and Boeing.
  • Bell's current strategic framework, NorthStar 2030, emphasizes defense technology, managed health, digital infrastructure and cyber, energy resilience, and mission software.

Interpretation

  • Leidos's history is defined less by a single proprietary product than by assembling a broad portfolio of mission-critical capabilities through corporate separation, major combinations, and targeted acquisitions.
  • The Lockheed Martin transaction was the pivotal scale event; Dynetics broadened advanced-defense capabilities; Kudu strengthened cyber; and Entrust materially increased exposure to energy infrastructure and commercial-adjacent engineering.
  • The acquisition-led history creates both an advantage and a risk: scale and cross-selling improve positioning, but integration, leverage, goodwill, and margin dilution can reduce shareholder returns if acquired businesses underperform.

Strengths and Moat

Strengths

  • Factor

    Mission-critical customer relationships

    Fact

    Leidos supports sensitive national-security, defense, health, transportation, and homeland-security missions for numerous government agencies.

    Interpretation

    Strong execution history, institutional knowledge, security clearances, and customer familiarity can make Leidos a credible incumbent and reduce the risk of displacement on complex programs.

  • Factor

    Scale and contract access

    Fact

    The company has approximately 50,000 employees, multibillion-dollar annual revenue, broad contract-vehicle access, and a large backlog.

    Interpretation

    Scale helps Leidos absorb compliance costs, maintain cleared technical talent, bid on large programs, and combine hardware, software, engineering, and managed services in a single proposal.

  • Factor

    Breadth of capabilities

    Fact

    The portfolio spans intelligence, cyber, defense, health, aviation security, border systems, engineering, energy infrastructure, and digital modernization.

    Interpretation

    Breadth can support cross-selling and make Leidos more relevant to large, multidomain government programs. It also reduces dependence on any one mission area, although the portfolio remains heavily dependent on U.S. government spending overall.

  • Factor

    Backlog and funding visibility

    Fact

    Leidos reported $48.711 billion of estimated backlog as of July 3, 2026, including $10.223 billion funded.

    Interpretation

    Backlog supports medium-term revenue visibility, but the large unfunded component is not equivalent to contracted cash flow and remains subject to appropriations, task-order awards, modifications, and execution.

  • Factor

    Security and regulatory barriers

    Fact

    Many programs require security clearances, specialized facilities, compliance systems, past performance, and technical qualifications.

    Interpretation

    These requirements create meaningful barriers to entry for smaller or newer competitors, particularly in classified and mission-critical work.

Competitors

  • Leidos identifies Accenture Federal Services, Amentum, BAE Systems, Booz Allen Hamilton, CACI International, Deloitte, General Dynamics, GovCIO, IBM, KBR, L3Harris Technologies, Lockheed Martin, ManTech, Northrop Grumman, Optum, Parsons, Peraton, RTX, and SAIC among its principal competitors.
  • Competition varies by program: Leidos faces large defense primes in systems and platforms, professional-services firms in consulting and digital work, specialized government contractors in intelligence and cyber, and commercial or industrial engineering firms in energy and infrastructure.

Where It Wins

  • Large, complex programs that require a combination of cleared personnel, systems integration, engineering, digital capabilities, operational support, and past performance.
  • Programs where incumbent knowledge, customer trust, security infrastructure, and the ability to manage distributed delivery are more important than a single low-cost product.
  • Cross-domain opportunities that connect defense, intelligence, health, homeland security, cyber, and infrastructure capabilities.

Where It Loses

  • Highly competitive procurements where price is the main differentiator and services are difficult to distinguish.
  • Programs requiring leading-edge commercial software platforms or consumer-scale product economics, where Leidos may compete against more focused technology companies.
  • Contracts exposed to fixed-price execution risk, labor shortages, supply-chain problems, schedule delays, or unfavorable changes in program scope.
  • Situations where a customer consolidates work with a larger incumbent, changes procurement vehicles, or shifts budget priorities.

Moat Assessment

Rating

Moderate and durable in selected niches, but not a wide corporate moat.

Durability

  • The strongest elements are accumulated past performance, security clearances, contract vehicles, technical workforce, classified infrastructure, compliance capabilities, and embedded customer knowledge.
  • These advantages are durable because they take time and money to build, but they do not eliminate competition. Government customers intentionally encourage competition, recompetes, multiple-award contracting, and price pressure.
  • Leidos's moat is therefore relationship- and execution-based rather than protected by patents, network effects, consumer switching costs, or a dominant proprietary software ecosystem.
  • The moat should be most durable in classified, technically complex, mission-critical, and operationally embedded programs. It is weaker in commoditized IT services, labor-based staffing, and open competitive bids where customers can compare providers largely on price and proposal quality.

Key Threats

  • Federal budget reductions or shifts away from the company's priority markets.
  • Losses on major recompetes or failure to win follow-on work.
  • Margin pressure from fixed-price contracts, wage inflation, subcontractor costs, and aggressive bidding.
  • Integration risk and leverage following acquisitions, especially Entrust.
  • Customer insourcing, commercial technology substitution, or procurement reform that lowers barriers to switching providers.

Bottom line

Leidos is a diversified government technology and mission-services contractor that earns most of its revenue from U.S. government programs across defense, intelligence, health, homeland security, cyber, and infrastructure. Its differentiation comes from scale, cleared talent, contract access, past performance, and the ability to integrate complex mission capabilities, but its moat is narrower than that of a proprietary software or platform company. The most important long-term variables are federal spending and priorities, recompete performance, fixed-price contract execution, the profitability of newer growth areas, and whether acquisitions such as Entrust create durable organic growth without excessive leverage or integration costs.

Sources

Advertisement

Part 2

Updated 2026-09-29

Current Situation & Why the Stock Is in a Rut

Leidos is in a stock-price rut despite solid operating execution because investors are discounting slower organic growth, lower year-over-year margins, higher leverage after the Entrust acquisition, government-budget uncertainty, and the possibility that recent earnings strength is not yet durable.

Recent Performance

Stock Context

  • LDOS closed at approximately $122.35 on September 28, 2026, according to the supplied scanner snapshot. Market data showed the stock down about 32% year to date and about 34% over the prior 12 months as of September 28, 2026.
  • The supplied scanner reports a trailing P/E of approximately 11.5x and price-to-book of approximately 2.9x. Its reported 139% dividend yield is not credible when compared with Leidos's declared quarterly dividend of $0.43 per share and is therefore unverified and likely a data error.

Last Three Reports

  • Date

    February 17, 2026

    Period

    Q4 fiscal 2025

    Facts

    • Revenue was $4.207 billion, down 4% year over year.
    • GAAP diluted EPS was $2.53, up 19% year over year; non-GAAP diluted EPS was $2.76, up 16%.
    • Adjusted EBITDA was $556 million, with a 13.2% margin versus 11.6% in the prior-year quarter.
    • Full-year 2025 revenue was $17.174 billion, up 3%; full-year non-GAAP EPS was $11.99, up 17%.
    • Management attributed the quarterly revenue decline partly to a six-week government shutdown and an extra work week in the comparison period.
    • Initial fiscal 2026 guidance was revenue of $17.5-$17.9 billion, non-GAAP EPS of $12.05-$12.45, mid-13% adjusted EBITDA margin, and approximately $1.75 billion of operating cash flow.
    • The company announced the $2.4 billion acquisition of Entrust Solutions Group shortly after the quarter, increasing investor concern about acquisition execution and leverage.

    Expectations And Stock Pressure

    • Reuters reported that fourth-quarter revenue missed Wall Street expectations and that the midpoint of initial 2026 adjusted EPS guidance was below the analyst estimate cited by Reuters.
    • The February 17 report was the clearest dated negative catalyst: the revenue miss, government-shutdown disruption, conservative initial outlook, and newly announced $2.4 billion acquisition combined to weaken the stock narrative even though EPS and margins improved.

  • Date

    May 5, 2026

    Period

    Q1 fiscal 2026

    Facts

    • Revenue was $4.400 billion, up 4% year over year and approximately $117 million above the Reuters-cited consensus estimate of $4.283 billion.
    • GAAP diluted EPS was $2.56 versus $2.77 in the prior-year quarter; non-GAAP diluted EPS was $3.13, up 5% year over year and above the Reuters-cited estimate of $2.90.
    • Adjusted EBITDA was $614 million, up 2%; adjusted EBITDA margin was 14.0% versus 14.2% a year earlier.
    • GAAP earnings were affected by $39 million of Entrust, joint-venture, and restructuring-related costs.
    • Quarterly bookings were $3.3 billion, producing a book-to-bill ratio of 0.8, although trailing-twelve-month book-to-bill was 1.1 and total backlog increased 4% year over year.
    • Management raised fiscal 2026 revenue guidance to $18.0-$18.4 billion, non-GAAP EPS guidance to $12.10-$12.50, and operating cash-flow guidance to approximately $1.80 billion.

    Expectations And Stock Pressure

    • The results were operationally strong and beat the available revenue and adjusted-EPS expectations, but the stock did not receive a durable re-rating. The likely investor concern was that the quarter still showed lower GAAP earnings, slightly lower margin, weak quarterly book-to-bill, and substantial acquisition-related financing needs.
    • Q1 cash flow was $301 million, while the Entrust acquisition required approximately $2.34 billion of cash consideration and increased debt to approximately $6.3 billion at April 3, 2026.

  • Date

    August 4, 2026

    Period

    Q2 fiscal 2026

    Facts

    • Revenue was $4.558 billion, up 7% year over year and approximately 4% organically.
    • GAAP diluted EPS was $2.81 versus $3.01 in the prior-year quarter; non-GAAP diluted EPS was $3.26 versus $3.21.
    • Adjusted EBITDA was $631 million versus $647 million; adjusted EBITDA margin fell to 13.8% from 15.2%.
    • GAAP net income declined to $356 million from $393 million, and GAAP net margin fell to 7.8% from 9.2%.
    • Management said the quarter included acquisition, integration, joint-venture, and restructuring costs, while the prior-year quarter benefited from a $25 million insurance reimbursement.
    • Operating cash flow was $793 million and non-GAAP free cash flow was $761 million.
    • Net bookings were approximately $5 billion, and management raised fiscal 2026 revenue guidance to $18.2-$18.4 billion, non-GAAP EPS guidance to $12.20-$12.50, and operating cash-flow guidance to approximately $1.85 billion.

    Expectations And Stock Pressure

    • Q2 was a fundamental beat on revenue, adjusted EPS, cash flow, and guidance, but the headline GAAP decline and 140-basis-point adjusted-EBITDA-margin contraction reinforced the market's concern that growth is not yet translating into sustained margin expansion.
    • The fact that non-GAAP EPS rose only 2% despite 7% reported revenue growth also limited the bullish interpretation.
    • No verified company-specific event after August 4 explains every subsequent share-price decline. The September weakness appears more consistent with valuation compression, sector rotation, and investor concern over margins and leverage than with a newly disclosed operational failure.

Performance Assessment

  • The recent earnings record is mixed for the stock but not for the underlying business: revenue and bookings improved, guidance was raised twice, and cash generation was strong.
  • The main negative signal is quality of growth. Organic Q2 growth was approximately 4%, while adjusted EBITDA declined 2% and margin fell sharply against a strong prior-year comparison.
  • The market appears to be valuing LDOS on normalized or forward earnings rather than rewarding isolated quarterly beats.

The Bear Case

Company Specific Problems

  • Margin normalization: Q2 adjusted EBITDA margin of 13.8% was materially below the 15.2% reported a year earlier. Some of the comparison was distorted by a prior-year insurance reimbursement, but the decline still raises questions about the durability of the 2025 margin expansion.
  • Low-growth profile: Q1 organic revenue growth was approximately 3% and Q2 organic revenue growth approximately 4%. That is respectable for a government contractor but not enough by itself to support a premium multiple.
  • Acquisition leverage and execution: Entrust was purchased for approximately $2.4 billion and funded partly with new debt. Debt rose from approximately $4.6 billion at January 2, 2026, to approximately $6.3 billion at April 3, 2026. Integration, interest expense, and achieving expected synergies are material risks.
  • Health and civil exposure: Leidos remains exposed to managed-healthcare programs and changing government healthcare incentives. Management has described the healthcare pillar as requiring greater visibility, which suggests that this segment is not yet a clean growth engine.
  • Backlog is not equivalent to revenue: Fiscal 2025 backlog was approximately $49.0 billion, but only approximately $9.7 billion was funded. Funding, task-order timing, protests, and government procurement delays can postpone conversion.
  • Cost and contract risk: Fixed-price programs, labor availability, security-clearance delays, cybersecurity requirements, contract protests, and program execution can pressure margins even when revenue remains stable.

Macro And Sector Headwinds

  • Government shutdowns, continuing resolutions, budget delays, sequestration, or changes in federal priorities can delay awards and revenue recognition.
  • Federal contractors face a mixed environment: defense-tech and cyber demand is strong, but civilian, healthcare, and administrative spending can be more exposed to cost controls and procurement scrutiny.
  • Higher interest rates and tighter valuation standards reduce the multiple investors are willing to pay for mature government-services companies, particularly when acquisitions increase leverage.
  • The sector is increasingly being divided between higher-growth technology-oriented contractors and lower-growth labor-intensive services firms. If Leidos is viewed as closer to the latter, its valuation may remain constrained.

Valuation

  • At the supplied price of $122.35 and the scanner's trailing P/E of approximately 11.5x, LDOS is inexpensive versus many defense-technology companies but not obviously distressed on an absolute earnings basis.
  • Using the midpoint of management's current non-GAAP EPS guidance of $12.35, the stock trades at approximately 9.9x forward non-GAAP EPS. This is attractive if guidance is achieved, but the multiple excludes acquisition amortization and other items that reduce GAAP earnings.
  • A February 2026 government-contractor valuation comparison placed LDOS around 11.1x EBITDA, below CACI at approximately 15.7x and above SAIC and Booz Allen in that particular comparison. The figures are third-party market data rather than company-reported figures, so they should be treated as directional.
  • LDOS's valuation is below the broader market and below higher-growth peers, but the discount is partly justified by slower organic growth, lower recent margins, leverage, and a less pure-play technology profile.
  • A reliable long-term historical average P/E for LDOS could not be verified from a primary source in this review. Therefore, the claim that the stock is at a record or multi-year valuation low is unverified.

Analyst Positioning

  • The available September 2026 consensus data showed a generally positive rating mix but many Hold ratings: one data set reported 4 Strong Buys, 3 Buys, 10 Holds, and no Sell or Strong Sell ratings among 17 analysts.
  • Recent target changes were mixed rather than uniformly bearish. Goldman Sachs lowered its target from $152 to $132 on August 12, 2026, while Citigroup raised its target from $138 to $161 on August 11, TD Cowen raised its target from $115 to $135 on August 7, and Bank of America raised its target from $125 to $135 in September.
  • The analyst pattern suggests limited conviction and valuation caution rather than a broad fundamental downgrade cycle.

Short Interest

  • Short interest was approximately 5.24 million shares as of September 15, 2026, with a short ratio of approximately 4.62 days according to market-data sources.
  • This is meaningful but not extreme for a large-cap contractor. It can amplify a rebound if estimates rise, but it is not by itself evidence of a heavily crowded short thesis.

Turnaround or Value Trap?

Bull Case

  • The business has high revenue visibility from government contracts, approximately $49 billion of backlog at fiscal 2025 year-end, and exposure to defense modernization, intelligence, cyber, energy infrastructure, air-traffic management, and mission software.
  • Management has raised fiscal 2026 revenue, EPS, and cash-flow guidance twice, which is stronger evidence than an isolated earnings beat.
  • Q2 bookings improved to approximately $5 billion, and management cited accelerating customer procurement activity and growth in Defense Tech, Energy Infrastructure, and Cyber.
  • Strong cash generation could allow Leidos to reduce leverage, continue share repurchases, fund dividends, and improve per-share earnings if Entrust performs as expected.
  • At roughly 10x the midpoint of current non-GAAP EPS guidance, even modest earnings growth or a return toward peer-average valuation could support a meaningful re-rating.

Bear Case

  • The earnings beats may be backward-looking while the market is focused on forward organic growth, which remains only mid-single digit.
  • Margin expansion may have peaked. Q2 showed that revenue growth can coexist with lower EBITDA and GAAP margins.
  • Entrust could produce disappointing returns on invested capital, prolong elevated leverage, or increase interest expense enough to offset operating gains.
  • A government funding disruption or procurement slowdown could delay backlog conversion and make current guidance difficult to achieve.
  • If the market classifies LDOS as a mature, low-growth systems integrator, a low-teens or high-single-digit earnings multiple may be appropriate even if the business remains healthy.

What Must Happen For Recovery

  • Organic revenue growth should sustain at approximately 5%-7% or better, with Q3 and Q4 demonstrating the expected second-half acceleration.
  • Adjusted EBITDA margin should stabilize near or above the mid-13% guidance level and begin expanding without relying on insurance reimbursements or other one-time benefits.
  • Quarterly book-to-bill should return above 1.0 consistently, with funded backlog growth converting into reported revenue.
  • Entrust integration should show measurable revenue contribution, cost synergies, and declining acquisition-related charges.
  • Debt should begin to decline after the acquisition, with interest expense no longer rising faster than operating income.
  • Management should maintain or raise fiscal 2026 guidance and provide credible 2027 growth and margin visibility.

Key Catalysts And Dates

  • Next earnings report: approximately November 3, 2026, according to market-calendar sources. This date is an estimate and is unverified by the company as of September 29, 2026.
  • Q3 results should provide the first meaningful test of whether the expected second-half acceleration is occurring.
  • Further large defense, intelligence, cyber, energy, or air-traffic-management awards could improve the market's view of bookings and backlog quality.
  • Debt reduction, successful Entrust integration, and evidence of margin stabilization would be stronger catalysts than another small adjusted-EPS beat.
  • The next dividend payment was scheduled for September 30, 2026, based on the company's declared $0.43 quarterly dividend; this is not likely to be a major valuation catalyst.

Metrics To Watch

  • Organic revenue growth by segment, especially Intelligence & Digital, Defense, and Homeland.
  • Adjusted EBITDA margin and GAAP operating margin.
  • Quarterly and trailing-twelve-month book-to-bill.
  • Funded backlog growth and conversion into revenue.
  • Operating cash flow, free-cash-flow conversion, and net debt.
  • Interest expense and leverage following the Entrust acquisition.
  • Acquisition and restructuring charges as a percentage of revenue.
  • Management's fiscal 2026 guidance status and any initial fiscal 2027 outlook.

Assessment

The bull case is credible because guidance has been raised twice, bookings improved in Q2, and cash flow is strong. The value-trap risk remains substantial because the stock has not responded to good results, organic growth is modest, margins are below the prior-year level, and leverage increased materially. The recovery thesis needs confirmation from Q3 and Q4 operating data rather than relying on the low headline P/E alone.

Evidence Assessment

Conclusion

Evidence is more consistent with temporary-to-cyclical pressure layered on top of moderate structural valuation constraints, rather than a clearly structural business breakdown.

Why

  • Temporary or cyclical factors include the six-week government shutdown, procurement delays, unusual prior-year comparisons, and a broad reassessment of federal-contractor valuations.
  • Evidence against a severe structural problem includes rising full-year guidance, positive revenue growth, strong cash flow, improving bookings in Q2, large backlog, and continued contract awards in defense, cyber, intelligence, and infrastructure.
  • Evidence for a structural concern includes slower organic growth than higher-growth peers, lower recent margins, dependence on government funding, acquisition-related leverage, and uncertainty over whether the NorthStar 2030 strategy can produce durable growth.
  • Overall, the data do not support calling LDOS a clear value trap yet, but they also do not justify assuming that a low P/E alone will cause a recovery.

Bottom line

Leidos is a diversified government technology, defense, intelligence, healthcare, infrastructure, cyber, and mission-services contractor with substantial backlog and recurring federal demand. The stock is stuck because investors are weighing strong revenue, bookings, cash flow, and raised guidance against modest organic growth, declining year-over-year margins, higher Entrust-related leverage, and government-budget uncertainty. The next major test is the expected Q3 report around November 3, 2026, with organic growth, book-to-bill, EBITDA margin, debt reduction, and Entrust integration more important than another isolated adjusted-EPS beat.

Sources

Advertisement
Advertisement

Research history

The current situation refreshes after a gap or at the 30-day consecutive Top-10 refresh point. Previous analyses are retained.